Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Medical Technologies has developed non-invasive nano-scale fluid sampling and testing systems that access subcutaneous interstitial fluid to electrochemically detect blood analytes. These devices enable continuous real-time monitoring of patient blood biomarkers, providing longitudinal data to support disease management. The technology is protected by several patents granted in analytical chemistry, drug delivery devices, and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Medical Technologies.